SecBot SecBot
SECBOTREPLAY Home › Report › ORMP

ORMP · COO/CBO Joshua Hexter and CFO Avraham Gabay collectively sold $942K in…

ORAMED PHARMACEUTICALS INC. · CLUSTER filed Jul 2, 2026 at 17:00 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Jul 2, 2026 at 17:00 ET

COO/CBO Joshua Hexter and CFO Avraham Gabay collectively sold $942K in open-market shares on July 1, 2026, representing ~0.5% of Oramed's $189M market cap. The sales are moderate in size and involve two senior officers, but insider selling is a weak directional signal per academic literature, especially without evidence of 10b5-1 plans or a clear blackout context.

  • Two C-suite insiders (COO/CBO and CFO) sold shares on July 1, 2026
  • Total open-market sales: $942,000 at ~$4.46-$4.51 per share
  • Sales represent ~0.5% of Oramed's $189M market cap
  • Hexter also exercised derivatives on July 2 (non-cash events)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access